A named circle of people who choose to make their belief structural.
BioFund was built on a simple conviction: that solving cancer requires a kind of commitment the venture capital industry is structurally incapable of making. Seven founding families made that commitment. They closed the door behind them. They called it no exit. They meant it.
In the years since, something consistent happened. People who had lost someone to cancer — or watched someone fight it — found their way to BioFund. Not as scientists. Not as investors. As believers. They arrived with two things: a clear understanding that the current system is wrong, and a desire to stand somewhere that is trying to make it right.
BioFund was not built to accommodate them. The seven founding families structure was deliberate — small enough to move with conviction, coherent enough to hold a single mission across decades.
But the people who arrived were serious. Their motivations were earned, not constructed. And they were asking a real question: is there a place for us?
The BioFund Circle is the answer.
"The first question Circle members ask is not 'what is the return?' It is: is this working?"
A charitable gift goes in one direction. It supports something from the outside. The giver and the mission remain separate — related by generosity, not by structure.
A conventional investment goes in one direction too, but expects a return in the other. It is oriented toward a moment of exit — a transaction that closes the relationship and distributes the gain.
The BioFund Circle is neither of these things. Circle members put real capital into a real structure and hold real units. The relationship has economic substance. But the first question Circle members ask is not "what is the return?" It is: is this working?
What Circle members hold is structural belonging — a named, legal, income-participating position inside the architecture of something built to outlast all of us. The difference between The Circle and a charitable gift is that Circle members are inside. The difference between The Circle and an investment is that the metric is not yield. It is progress.
That is not charity. It is not investment in the conventional sense. It is a third thing — which is why it required a new structure.
The BioFund Circle LP is a Canadian Limited Partnership managed by BioFund Ventures Inc. as General Partner. Circle members are Limited Partners — silent by design and by law. The structure of a Canadian LP makes this explicit: Limited Partners who do not exercise control over operations are protected from the weight of decisions that are not theirs to carry.
The LP holds two classes of units, each non-transferable. Once The Circle is full, it is full. There is no second round, no expansion mandate, no future raise.
Named in perpetuity in the founding documents of The BioFund Circle LP. The people who said yes before there was a track record, before there was a gathering, before the idea had a name. Seven seats. When they are filled, they are filled.
Admitted over time at the discretion of BioFund Ventures Inc. The same rights, the same access, the same annual gathering as Founding Unit holders. A wider group — still small, still personal, still by invitation only.
BioFund's technology platforms — UFP500°, biodeep.ai, micronutri.ai — and RAFFINÉ, its functional culinary brand, are built to generate commercial revenue. RAFFINÉ operates explicitly on the principle that every cent of commercial revenue funds cancer research. That principle does not change with The Circle.
The revenue generated by the commercial layer flows in a defined order of priority. Circle members sit at the end of that chain — not as an afterthought, but as the proof that the mission is generating enough momentum to give something back.
The income is not the point. It is proof that the point is working.
The format is fixed. An intimate dinner. RAFFINÉ hospitality. One member of the BioFund science team presenting — not a pitch, not a performance, a genuine account of where the work stands. Annual distributions are announced in person, at the table. The founding document of The Circle is present.
The gathering is not a reporting event. It is not a board meeting. It is the lived reality of what The Circle is — a group of people who chose to believe in something difficult, and are watching it move.
When a distribution is announced at the table, it is not a return on an investment. It is proof that the mission is working.
The founding families built BioFund. The Circle extends it — not in scope, not in governance, not in scientific direction, but in the human architecture that surrounds the mission.